Vaccine Contract Manufacturing Market Enhancing Huge Growth and Latest Trends by Top Players 2023-202

1
Global Vaccine Contract Manufacturing Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Vaccine Contract Manufacturing Market
Research Report The latest report by IMARC,
titled Vaccine Contract Manufacturing Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028 " the global
vaccine contract manufacturing market reached a
value of US 2.5 Billion in 2022. Vaccine
contract manufacturing involves outsourcing of
large-scale production of vaccines to Contract
Manufacturing Organizations (CMOs) to offer
cost-saving benefits to their clients. These
contract organizations offer a vast array of
services, including stability studies,
pre-clinical activities, pre-formulation work,
formulation development, registration batches,
method development, and commercial manufacturing.
The outsourcing of these services also assists in
saving time and resources related to operations
and management of production and research
facilities. The CMOs also offer innovative
technologies that aid in expanding the production
chain of pharmaceutical companies. Request Free
Sample Report https//www.imarcgroup.com/vaccine-
contract-manufacturing-market/requestsample
4
Report Description and Highlights
Report Description

Global Vaccine Contract Manufacturing Market
Trends The global market is primarily driven
by the increasing incidences of infectious
diseases, such as coronavirus disease (COVID-19)
and hepatitis-B, across the globe. Along with
this, the rising awareness regarding the pivotal
role of vaccines in improving health and boosting
immunity has resulted in the growing demand for
vaccine contract manufacturing on the global
level. This is further supported by the reduced
development costs and complex production
protocols of vaccines. The market is also driven
by the increasing demand for vaccine development
from the private and government sectors. Numerous
organizations are also undertaking initiatives to
spread awareness regarding the importance of
vaccination, which is creating a positive outlook
for the market. Apart from this, the widespread
integration of advanced technologies with
contract manufacturing is also providing an
impetus to the market growth. For instance, the
advent of expression systems, including the EB66
and GPEx and cell culture media platforms, are
acting as major growth-inducing factors. Some of
the other factors contributing to the market
growth include lack of skilled labor in numerous
countries and extensive research and development
(RD) activities. On account of the
aforementioned factors, the market is anticipated
to grow at a CAGR of 10.8 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Vaccine Type
Attenuated Inactivated Subu
nit-based Toxoid-based DNA-bas
ed Breakup by Workflow Downstream
Fill and Finish Operations
Analytical and QC Studies
Packaging Upstream
Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Baculovirus/Insect Expression
Systems

6
Report Description and Highlights
Report Description
Others Breakup by Application
Human Use Veterinary Breakup
by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Australia
Indonesia Others
Europe Germany

7
Report Description and Highlights
Report Description
France United
Kingdom Italy
Spain Russia O
thers Latin America Br
azil Mexico Ot
hers Middle East and Africa Note We ar
e updating our reports, If you want latest
primary and secondary data (2023-2028) with Cost
Module, Business Strategy, Distribution Channel,
etc. Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Albany Molecular Research Inc Catalent Inc Cobra B
  iologics Limited (Charles River Laboratories
  International Inc.) Cytovance Biologics Inc. (Hepa
  link USA Inc.) Fujifilm Holdings Corporation ICON
  plc IDT Biologika GmbH Lonza Group AG Merck KGaA P
  harmaceutical Product Development LLC
  PRA Health Sciences Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/vaccine-contract-manufa
  cturing-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us